scholarly journals Positive Anti-GABAB Receptor Antibodies in a Patient with Hashimoto’s Thyroiditis and Bipolar Affective Disorder

2021 ◽  
pp. 1-3
Author(s):  
Polina A. Sobolevskaia ◽  
Boris V. Andreev ◽  
Leonid P. Churilov ◽  
Tamara V. Fedotkina ◽  
Boris Gilburd ◽  
...  

A kind of autoimmune encephalitis with positive autoantibodies toward the B1 subunit of the gamma-aminobutyric acid-type B receptor is known as anti-GABABR encephalitis. It is an autoimmune brain disorder with typical manifestations of a limbic encephalitis. It can coexist with positive anti-thyroid autoantibodies. We described a 57-year-old woman who was diagnosed with a bipolar affective disorder. The patient had high titers of anti-thyroid peroxidase antibodies, and she also was positive for anti-GABABR antibodies. There is a question, if this case is a kind of comorbidity of anti-thyroid and anti-brain autoimmunity or is it a single nosological entity – a kind of Hashimoto’s encephalopathy?

Medicine ◽  
2019 ◽  
Vol 98 (20) ◽  
pp. e15706 ◽  
Author(s):  
Ha-Yeun Chung ◽  
Jonathan Wickel ◽  
Annika Voss ◽  
Mihai Ceanga ◽  
Josefine Sell ◽  
...  

2020 ◽  
Vol 59 (6) ◽  
pp. 843-847 ◽  
Author(s):  
Yuki Kitazaki ◽  
Masamichi Ikawa ◽  
Tomohisa Yamaguchi ◽  
Soichi Enomoto ◽  
Toru Kishitani ◽  
...  

2019 ◽  
Vol 20 (2) ◽  
pp. 139-143 ◽  
Author(s):  
Kiran Samra ◽  
Jonathan Rogers ◽  
Mohamed Mahdi-Rogers ◽  
Biba Stanton

A 22-year-old African woman developed acute behavioural change, against a background of sickle cell disease with strokes requiring a ventriculoperitoneal shunt. She alternated between mutism with prolonged staring and posturing, and a state of agitation with elation and echolalia. Cerebrospinal fluid (CSF) protein was elevated and electroencephalogram showed mild slowing with bitemporal slow and sharp waves. We suspected catatonia secondary to possible autoimmune encephalitis but her condition persisted despite intravenous methylprednisolone. After identifying a positive serum anti-gamma-aminobutyric acid-A (GABAA) antibody, treatment with intravenous immunoglobulin, oral corticosteroids and rituximab led to gradual improvement. Patients with catatonia may show reduced GABAA receptor density and there are two other reports of catatonia with anti-GABAA antibodies. This patient’s treatment response supports the antibody’s causative role.


Sign in / Sign up

Export Citation Format

Share Document